PREVENT VACCINE REACTIONS
 Your health. Your family. Your choice.

Chickenpox and Chickenpox Vaccine

What is Chickenpox?

Chickenpox is caused by the varicella zoster virus, which is a member of the herpesvirus family and is associated with herpes zoster (shingles). Chickenpox is highly contagious but for the majority of children it is a mild disease characterized by small round lesions on the skin that cause intense itching. It lasts from two to three weeks and recovery from the disease usually gives permanent immunity to it. Half of all cases occur in children between the ages of 5 and 9. It has been estimated that only 10 percent of Americans over the age of 15 have never had chickenpox.

Can Chickenpox Cause Injury and Death?

Yes. 3.7 million cases of varicella were estimated to occur in the US annually in the early 1990s. Data from 1992 showed that about 158,000 cases of chickenpox were reported and 100 deaths were reported. More than half of the deaths were in adults because chickenpox is more serious in adults than in children. Up to 20 percent of adults who get chickenpox can develop severe complications such as pneumonia. Other rare complications from chickenpox include serious bacterial infection of the lesions and brain inflammation, which is reported in less than one percent of children who get chickenpox. Most children and adults who develop severe complications from chickenpox disease have compromised immune systems or other health problems.

What is Chickenpox Vaccine?

The Varicella Zoster (chickenpox) vaccine is made from the Oka/Merck strain of live attenuated (weakened) varicella virus. The virus was initially obtained from a child with natural varicella, introduced into human embryonic lung cell cultures, adapted to and propagated in embryonic guinea pig cell cultures, and finally propagated in human diploid cell cultures. The vaccine contains sucrose, phosphate, glutamate and processed gelatin as stabilizers.

How Effective is Chickenpox Vaccine?

All vaccines only provide temporary immunity. Only recovery from natural chickenpox disease will provide lifelong immunity. When the chickenpox vaccine was licensed for public use in 1995, the Food and Drug Administration (FDA) estimated that it was 70 to 90 percent effective in preventing disease. A recent Centers for Disease Control (CDC) study (Dec. 2002) reported that "the effectiveness of the vaccine was 44 percent against disease of any severity and 86 percent against moderate or severe disease." Some are suggesting a second dose of chickenpox vaccine may be needed. Another study in 2002 confirmed that adults exposed to natural chickenpox disease were protected from developing shingles and that there is concern that mass vaccination against chickenpox may cause a future epidemic of shingles, affecting more than 50 percent of Americans aged 10 to 44 years.

Can Chickenpox Vaccine Cause Injury and Death?

Yes. Between March 1995 and July 1998, the federal Vaccine Adverse Events Reporting System (VAERS) received 6, 574 reports of health problems after chickenpox vaccination. That translates into 67.5 adverse events per 100,000 doses of vaccine or one in 1,481 vaccinations. About four percent of cases (about 1 in 33,000 doses) were serious including shock, encephalitis, thrombocytopenia (blood disorder) and 14 deaths. The VAERS data has led to the addition of 17 adverse events to the manufacturer's product label since the vaccine was licensed in 1995, including secondary bacterial infections (cellulitis), secondary transmission of vaccine virus infection to close contacts, transverse myelitis and Guillain Barre syndrome (brain disorders) and herpes zoster (shingles). There have been documented cases of transmission of vaccine virus from a vaccinated child to household contacts, including a pregnant woman. A study in 2002 confirmed that adults exposed to natural chickenpox disease were protected from developing shingles and that there is concern that mass vaccination against chickenpox may cause a future epidemic of shingles, affecting more than 50 percent of Americans aged 10 to 44 years.

Should Chickenpox Vaccine Be Mandated?

No. The majority of children who recover from chickenpox disease do not suffer complications and they are left with lifelong immunity to the disease. The chickenpox vaccine only gives temporary immunity and leaves children vulnerable to disease later in life when complications from chickenpox can be much more serious. Vaccine reaction reports suggest that the vaccine is more reactive than it was thought to be before licensure and there are too many outstanding questions about the true adverse event profile of this live virus vaccine. Parents should have a choice about whether or not to vaccinate their children with the chickenpox vaccine.

 
BARBARA LOE FISHER
SPEAKS OUT
ABOUT BARBARA LOE FISHER

ARTICLES AND INTERVIEWS

CNN
Vaccinations....or Jail,
November 15
, 2007

TODAY SHOW
Exemptions and Mandates, October 19, 2007

NPR- VERMONT EDITION
Vaccine Mandates, August 20, 2007
 
CHRISTIAN BROADCASTING NETWORK
Are Vaccinations Safe for Your Kids? August 1, 2007

TODAY SHOW
Should HPV Vaccine Be Mandatory?
February 13, 2007

VACCINE, by Arthur Allen
January 5, 2007

MOTHERING MAGAZINE
In the Wake of Vaccines Sept/Oct 2004

THE BRIAN LEHRER SHOW
Public Health vs Parents' Fears 10/9/03
INSIGHT MAGAZINE
Vaccines fueling autism epidemic?  6/9/03

CBS NEWS

THE EARLY SHOW, 12/04/02

THE DIANE REHM SHOW
NPR, 11/13/02

INTERVIEW WITH PAULA ZAHN
CNN, 02/25/02

INTERVIEW

NEW YORK TIMES MAG, 5/06/01

SHOULD PARENTS BE ALLOWED TO OPT OUT OF VACCINATING THEIR KIDS?
INSIGHT, 4/24/2000

BUILDING KNOWLEDGE AND TRUST
CHIROPEDIATRIC TIMES, AUG. 2001

AUDIO INTERVIEW
EMERGING WORLDS, 2001

SHOTS IN THE DARK
NEXT CITY, Summer 1999

TESTIMONY

7/14/2005
PROJECT BIOSHIELD

9/10/2003
SV40 AND CANCER


1/23/2002
CA SENATE ON IMMUNIZATION MANDATES

[MORE TESTIMONY]

STATEMENTS

4/11/08
VACCINE SAFETY RESEARCH PRIORITIES: ENGAGING THE PUBLIC

 02/23/07
20/20 RESPONSE

July 20, 2005
POWER OF TRUTH RALLY

8/23/04
SHARE VACCINE DATA- INSTITUTE OF MEDICINE

6/26/02
ANTI-VACCINE WEBSITES

6/24/02
SMALLPOX VACCINE PLAN

1/11/01
IOM IMMUNIZATION SAFETY COMMITTEE STATEMENT BY BARBARA LOE FISHER


[MORE TOPICS]

NVIC NEWSLETTERS
FALL 2005
THE VACCINE HOTLINE


FALL 2004

THE VACCINE HOTLINE


SPRING 2004

FLU VACCINE: MISSING THE MARK

WINTER 2002
SMALLPOX & FORCED VACCINATION


SPRING 2000
AUTISM & VACCINES


SEPTEMBER 1998
HEPATITIS B VACCINE

[MORE NEWSLETTERS]
 

NVIC PRESS RELEASES
AUGUST 15, 2007 
ANALYSIS SHOWS GREATER RISK OF GBS REPORTS WHEN HPV VACCINE IS GIVEN WITH OTHER VACCINES

FEBRUARY 2 1, 2007 
VACCINE SAFETY GROUP RELEASES GARDASIL REACTION REPORT


FEBRUARY 1, 2007 
HPV VACCINE MANDATES RISKY AND EXPENSIVE

OCTOBER 31, 2006 
STUDIES FAIL TO DEMONSTRATE SAFETY OR EFFECTIVENESS OF INFLUENZA VACCINE IN CHILDREN OR ADULTS

OCTOBER 16, 2006 
SAFETY ADVOCATES OPPOSE PENTAGON'S RETURN TO MANDATORY ANTHRAX VACCINATION OF U.S. MILITARY PERSONNEL

JUNE 27, 2006 

MERCK'S GARDASIL NOT PROVEN SAFE FOR LITTLE GIRLS 


NOVEMBER 15, 2005   

CONGRESS SET TO BAIL OUT BIG PHARMA IN SECRET 



OCTOBER 19, 2005   

CONGRESS SET TO PASS LAW ELIMINATING LIABILITY FOR VACCINE INJURIES 


JUNE 6, 2005   

PRESIDENT BUSH SHOULD REMOVE MERCURY FROM VACCINES

APRIL 1, 2005   
NVIC TEAMS UP WITH ANTHRAX BAND

FEB 4, 2005   
ANTI-TERROR BILL UNCONSTITUTIONAL

MAY 18, 2004   
IOM PLAYED POLITICS IN REPORT ON AUTISM AND VACCINES

DECEMBER  10, 2003
GOVERNMENT AND INDUSTRY SHOULD RELEASE FLU VACCINE DATA


DECEMBER  8, 2003
VACCINE SAFETY ADVOCATES SUPPORT SENATOR'S RESOLUTION


[MORE PRESS RELEASES]

NVIC CONFERENCES

Home Page | About Us | NVIC Store | Membership Donation | Links | Contact Us

National Vaccine Information Center · 407 Church Street, Suite H · Vienna, VA 22180 · 1-703-938-0342

Site Designed and Hosted by InfoVision, Inc.